Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Filed with HKEX · Stock code 2228 · · 11 pages · English
Summary by 6ix AI
It includes information on the company's authorized and registered share capital, which remained unchanged at the end of the month. The report also confirms compliance with public float requirements and provides details on movements in issued and treasury shares. Notably, there was a decrease in issued shares and an increase in treasury shares during the reporting period.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
XtalPi Holdings Limited on 6ix
Earlier from XtalPi
- Next Day Disclosure Return
- XtalPi Advances Hair Loss Drug Program into IND-Enabling Studies
- XtalPi and Fangda Carbon Deploy Predictive AI to Optimize Cost and Material Efficiency in Graphite Electrode Manufacturing
- XtalPi Submits U.S. FDA IND Application for KQTD-126, a Potential First-in-Class, Gut-Restricted Pan-TRK Inhibitor for Chronic Intestinal Pain
- Grant of share options and restricted share units
Later from XtalPi
- Voluntary announcement increase in shareholding in the company by the chairman of the board
- Voluntary announcement further increase in shareholding by chairman of the board
Follow XtalPi into a list and get an email when it puts out news.
Follow XtalPi